Literature DB >> 10570485

G-protein-coupled inwardly rectifying potassium channels are targets of alcohol action.

J M Lewohl1, W R Wilson, R D Mayfield, S J Brozowski, R A Morrisett, R A Harris.   

Abstract

G-protein-coupled inwardly rectifying potassium channels (GIRKs) are important for regulation of synaptic transmission and neuronal firing rates. Because of their key role in brain function, we asked if these potassium channels are targets of alcohol action. Ethanol enhanced function of cerebellar granule cell GIRKs coupled to GABAB receptors. Enhancement of GIRK function by ethanol was studied in detail using Xenopus oocytes expressing homomeric or heteromeric channels. Function of all GIRK channels was enhanced by intoxicating concentrations of ethanol, but other, related inwardly rectifying potassium channels were not affected. GIRK2/IRK1 chimeras and GIRK2 truncation mutants were used to identify a region of 43 amino acids in the carboxyl (C) terminus that is critical for the action of ethanol on these channels.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10570485     DOI: 10.1038/16012

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  89 in total

1.  Mechanism underlying bupivacaine inhibition of G protein-gated inwardly rectifying K+ channels.

Authors:  W Zhou; C Arrabit; S Choe; P A Slesinger
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-15       Impact factor: 11.205

2.  Reduced ethanol-induced conditioned taste aversion and conditioned place preference in GIRK2 null mutant mice.

Authors:  Katherine G Hill; Herminia Alva; Yuri A Blednov; Christopher L Cunningham
Journal:  Psychopharmacology (Berl)       Date:  2003-04-30       Impact factor: 4.530

3.  A pervasive mechanism for analgesia: activation of GIRK2 channels.

Authors:  Y A Blednov; M Stoffel; H Alva; R A Harris
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-19       Impact factor: 11.205

Review 4.  Virogenetic and optogenetic mechanisms to define potential therapeutic targets in psychiatric disorders.

Authors:  Ming-Hu Han; Allyson K Friedman
Journal:  Neuropharmacology       Date:  2011-09-17       Impact factor: 5.250

5.  Gating of a G protein-sensitive mammalian Kir3.1 prokaryotic Kir channel chimera in planar lipid bilayers.

Authors:  Edgar Leal-Pinto; Yacob Gómez-Llorente; Shobana Sundaram; Qiong-Yao Tang; Tatyana Ivanova-Nikolova; Rahul Mahajan; Lia Baki; Zhe Zhang; Jose Chavez; Iban Ubarretxena-Belandia; Diomedes E Logothetis
Journal:  J Biol Chem       Date:  2010-10-06       Impact factor: 5.157

Review 6.  Behavioral and Genetic Evidence for GIRK Channels in the CNS: Role in Physiology, Pathophysiology, and Drug Addiction.

Authors:  Jody Mayfield; Yuri A Blednov; R Adron Harris
Journal:  Int Rev Neurobiol       Date:  2015-06-22       Impact factor: 3.230

7.  Identification of a G-Protein-Independent Activator of GIRK Channels.

Authors:  Yulin Zhao; Peter Man-Un Ung; Gergely Zahoránszky-Kőhalmi; Alexey V Zakharov; Natalia J Martinez; Anton Simeonov; Ian W Glaaser; Ganesha Rai; Avner Schlessinger; Juan J Marugan; Paul A Slesinger
Journal:  Cell Rep       Date:  2020-06-16       Impact factor: 9.423

Review 8.  Low dose acute alcohol effects on GABA A receptor subtypes.

Authors:  Martin Wallner; H Jacob Hanchar; Richard W Olsen
Journal:  Pharmacol Ther       Date:  2006-07-11       Impact factor: 12.310

Review 9.  The recent progress in research on effects of anesthetics and analgesics on G protein-coupled receptors.

Authors:  Kouichiro Minami; Yasuhito Uezono
Journal:  J Anesth       Date:  2012-10-26       Impact factor: 2.078

Review 10.  Alterations in the levels of heterotrimeric G protein subunits induced by psychostimulants, opiates, barbiturates, and ethanol: Implications for drug dependence, tolerance, and withdrawal.

Authors:  Nobue Kitanaka; Junichi Kitanaka; F Scott Hall; Tomohiro Tatsuta; Yoshio Morita; Motohiko Takemura; Xiao-Bing Wang; George R Uhl
Journal:  Synapse       Date:  2008-09       Impact factor: 2.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.